Sjögren's syndrome: Why autoimmune epithelitis?

Oral Diseases

Volumn 12, Issue 6, 2006, Pages 523-532

  Mitsias, D I ^a   Kapsogeorgou, E K ^a   Moutsopoulos, H M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antigen presenting cell; Apoptosis; Autoimmune epithelitis; Epithelial cell; Extraglandular manifestations; Sj gren's syndrome

Indexed keywords

ANTIGEN; CHEMOKINE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CYTOKINE PRODUCTION; EPITHELIUM CELL; EXOCRINE GLAND; GERMINAL CENTER; HUMAN; KIDNEY EPITHELIUM; LIVER; LUNG ALVEOLUS EPITHELIUM; MOLECULAR MECHANICS; NOMENCLATURE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; THEORETICAL STUDY; THYROID GLAND; XEROSTOMIA;

ANTIGEN-PRESENTING CELLS; AUTOIMMUNITY; EPITHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; SJOGREN'S SYNDROME; TERMINOLOGY; VIRUS ACTIVATION;

EID: 33750354497     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01292.x     Document Type: Review

References (96)

1. Abraham S, Begum S, Isenberg D (2004). Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63: 123-129.
2. Abu Helu RF, Dimitriou ID, Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN (2001). Induction of salivary gland epithelial cell injury in Sjögren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression. J Autoimmun 17: 141-153.
3. Aichinger G, Fill H, Wick G (1985). In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis. Lab Invest 52: 132-140.
4. Al-Hashimi I, Khuder S, Haghighat N, Zipp M (2001). Frequency and predictive value of the clinical manifestations in Sjögren's syndrome. J Oral Pathol Med 30: 1-6.
5. Amft N, Curnow SJ, Scheel-Toellner D et al (2001). Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum 44: 2633-2641.
6. Arrieta JJ, Rodriguez-Inigo E, Ortiz-Movilla N et al (2001). In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 158: 259-264.
7. Barone F, Bombardieri M, Manzo A et al (2005). Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum 52: 1773-1784.
8. Bertram U, Halberg P (1965). Organ antibodies in Sjögren's syndrome. Acta Allergol 20: 472-483.
9. Bossini N, Savoldi S, Franceschini F et al (2001). Clinical and morphological features of kidney involvement in primary Sjögren's syndrome. Nephrol Dial Transplant 16: 2328-2336.
10. Boumba D, Skopouli FN, Moutsopoulos HM (1995). Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheumatol 34: 326-333.
11. Cain HC, Noble PW, Matthay RA (1998). Pulmonary manifestations of Sjögren's syndrome. Clin Chest Med 19: 687-699, viii.
12. Coll J, Anglada J, Tomas S et al (1997). High prevalence of subclinical Sjögren's syndrome features in patients with autoimmune thyroid disease. J Rheumatol 24: 1719-1724.
13. Constantopoulos SH, Moutsopoulos HM (1986). Respiratory involvement in patients with primary Sjögren's syndrome. Is it a problem? Scand J Rheumatol 61(Suppl.): 146-150.
14. Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM (1985). Respiratory manifestations in primary Sjögren's syndrome. A clinical, functional, and histologic study. Chest 88: 226-229.
15. D'Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P, Pennec YL (2003). Thyroid dysfunction in primary Sjögren's syndrome: a long-term follow up study. Arthritis Rheum 49: 804-809.
16. Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM (1991). Alveolitis correlates with clinical pulmonary involvement in primary Sjögren's syndrome. Chest 99: 1394-1397.
17. Davidson BK, Kelly CA, Griffiths ID (2000). Ten year of follow up of pulmonary function in patients with primary Sjögren's Syndrome. Ann Rheum Dis 59: 709-712.
18. Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR (1996). Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 154: 794-799.
19. Dimitriou ID, Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN (2002). CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation. Clin Exp Immunol 127: 386-392.
20. Fabini G, Rutjes SA, Zimmermann C, Pruijn GJ, Steiner G (2000). Analysis of the molecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNA binding proteins. Eur J Biochem 267: 2778-2789.
21. Fulda S, Debatin KM (2002). IFN-γ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 21: 2295-2308.
22. Goules A, Masouridi S, Tzioufas AG, Ioannidis JP, Skopouli FN, Moutsopoulos HM (2000). Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome. Medicine (Baltimore) 79: 241-249.
23. Grewal IS, Flavell RA (1998). CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16: 111-135.
24. Groom J, Kalled SL, Cutler AH et al (2002). Association of BAFF/BLyS over expression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 109: 59-68.
25. Haddad J, Deny P, Munz-Gotheil C et al (1992). Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339: 321-323.
26. Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF (1983). Aberrant expression of HLA-DR antigens on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2: 1111-1115.
27. Hansen BU, Lindgren S, Eriksson S et al (1988). Clinical and immunological features of Sjögren's syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis. Acta Med Scand 224: 611-619.
28. Hansen BU, Ericsson UB, Henricsson V, Larsson E, Manthorpe R, Warfvinge G (1991). Autoimmune thyroiditis and primary Sjögren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clin Exp Rheumatol 9: 137-141.
29. Hatron PY, Wallaert B, Gosset D et al (1987). Subclinical lung inflammation in primary Sjögren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum 30: 1226-1231.
30. Humphreys-Beher MG, Peck AB, Dang H, Talal N (1999). The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome. Clin Exp Immunol 116: 383-387.
31. Ito I, Nagai S, Kitaichi M et al (2005). Pulmonary manifestations of primary Sjögren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171: 632-638.
32. Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN (2001a). Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with CD28 receptor, but has reduced binding to CTLA4. J Immunol 166: 3107-3113.
33. Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN (2001b). Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 124: 126-133.
34. Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN (2005). Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum 52: 1517-1521.
35. Karsh J, Pavlidis N, Weintraub BD, Moutsopoulos HM (1980). Thyroid disease in Sjögren's syndrome. Arthtritis Rheum 23: 1326-1329.
36. Kaserer K, Exner M, Mosberger I, Penner E, Wrba F (1998). Characterization of the inflammatory infiltrate in autoimmune cholangitis. A morphological and immunhistochemical study. Virchows Arch 432: 217-222.
37. Kassan SS, Moutsopoulos HM (2004). Clinical manifestations and early diagnosis of Sjögren's syndrome. Arch Intern Med 164: 1275-1284.
38. Kong L, Ogawa N, Nakabayashi T et al (1997). Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 40: 87-97.
39. Kong L, Ogawa N, McGuff HS et al (1998). Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol 88: 133-141.
40. Manganelli P, Fietta P (2003). Apoptosis and Sjogren syndrome. Semin Arthritis Rheum 33: 49-65.
41. Manoussakis MN, Dimitriou ID, Kapsogeorgou EK et al (1999). Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. Arthritis Rheum 42: 229-239.
42. Martin SJ, Reutelingsperger CP, McGahon AJ et al (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182: 1545-1556.
43. Matsumura R, Umemiya K, Kagami M et al (1998a). Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome. Clin Exp Rheumatol 16: 561-568.
44. Matsumura R, Umemiya K, Nakazawa T et al (1998b). Expression of cell adhesion molecules in tubulointerstitial nephritis associated with Sjögren's syndrome. Clin Nephrol 49: 74-81.
45. Matsumura R, Umemiya K, Goto T et al (2000). Interferon gamma and tumor necrosis factor alpha induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line. Clin Exp Rheumatol 18: 311-318.
46. Matsumura R, Umemiya K, Goto T et al (2001). Glandular and extraglandular expression of costimulatory molecules in patients with Sjögren's syndrome. Ann Rheum Dis 60: 473-482.
47. Matsuyama N, Ashizawa K, Okimoto T, Kadota J, Amano H, Hayashi K (2003). Pulmonary lesions associated with Sjögren's syndrome: radiographic and CT findings. Br J Radiol 76: 880-884.
48. McArthur C, Wang Y, Veno P, Zhang J, Fiorella R (2002). Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alphafodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha. Arch Oral Biol 47: 443-448.
49. Montoya MC, Sancho D, Vicente-Manzanares M, Sanchez-Madrid F (2002). Cell adhesion and polarity during immune interactions. Immunol Rev 186: 68-82.
50. Moutsopoulos HM (1994). Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 72: 162-165.
51. Moutsopoulos HM, Balow JE, Lawley TJ, Stahl NI, Antonovych TT, Chused TM (1978). Immune complex glomerulonephritis in sicca syndrome. Am J Med 64: 955-960.
52. Moutsopoulos HM, Hooks JJ, Chan CC, Dalavanga YA, Skopouli FN, Detrick B (1986). HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Ann Rheum Dis 45: 677-683.
53. Moutsopoulos HM, Tzioufas AG, Bai MK, Papadopoulos NM, Papadimitriou CS (1990). Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands. Ann Rheum Dis 49: 929-931.
54. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S (2002). Involvement of the interferon-γ-induced T cell-attracting chemokines, interferon-γ- inducible 10-kd protein (CXCL10) and monokine induced by interferon-γ (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum 46: 2730-2741.
55. Ohlsson M, Szodoray P, Loro LL, Johannessen AC, Jonsson R (2002a). CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary glands: a putative anti-apoptotic role during its effector phases. Scand J Immunol 56: 561-571.
56. Ohlsson M, Jonsson R, Brokstad KA (2002b). Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol 56: 456-469.
57. Ohyama Y, Nakamura S, Hara H et al (1998). Accumulation of human T lymphotropic virus type I-infected T cells in the salivary glands of patients with human T lymphotropic virus type I-associated Sjögren's syndrome. Arthritis Rheum 41: 1972-1978.
58. Papiris SA, Saetta M, Turato G et al (1997). CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome. Am J Respir Crit Care Med 156(2 Pt 1): 637-641.
59. Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN (1999). Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 58: 61-64.
60. Parkin B, Chew JB, White VA, Garcia-Briones G, Chhanabhai M, Rootman J (2005). Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome? Ophthalmology 112: 2040-2047.
61. Perez B, Kraus A, Lopez G, Cifuentes M, Alarcon-Segovia D (1995). Autoimmune thyroid disease in primary Sjögren's syndrome. Am J Med 99: 480-484.
62. Pers JO, Daridon C, Devauchelle V et al (2005). BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 1050: 34-39.
63. Ping L, Ogawa N, Sugai S (2005). Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome. Arthritis Rheum 52: 573-581.
64. Polihronis M, Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM (1998). Modes of epithelial cell death and repair in Sjögren's syndrome (SS). Clin Exp Immunol 114: 485-490.
65. Ramos-Casals M, Garcia-Carrasco M, Cervera R et al (2000). Thyroid disease in primary Sjogren syndrome. Study in a series of 160 patients. Medicine (Baltimore) 79: 103-108.
66. Ramos-Casals M, DeVita S, Tzioufas AG (2005). Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 4: 8-15.
67. Ravald N, List T (1998). Caries and periodontal conditions in patients with primary Sjögren's syndrome. Swed Dent J 22: 97-103.
68. Rosenberg ME, Schendel PB, McCurdy FA, Platt JL (1988). Characterization of immune cells in kidneys from patients with Sjögren's syndrome. Am J Kidney Dis 11: 20-22.
69. Royer B, Cazals-Hatem D, Sibilia J et al (1997). Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 90: 766-775.
70. Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M (2002). Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 55: 336-342.
71. Salomonsson S, Jonsson MV, Skarstein K et al (2003). Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 48: 3187-3201.
72. Scott CA, Avellini C, Desinan L et al (1997). Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome. Histopathology 30: 41-48.
73. Skopouli FN (2001). Kidney injury in Sjögren's syndrome. Nephrol Dial Transplant 16(Suppl. 6): 63-64.
74. Skopouli FN, Barbatis C, Moutsopoulos HM (1994). Liver involvement in primary Sjögren's syndrome. Br J Rheumatol 33: 745-748.
75. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM (2000). Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 29: 296-304.
76. Slobbe RL, Pluk W, van Venrooij WJ, Pruijn GJ (1992). Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions. J Mol Biol 227: 361-366.
77. Spachidou MP, Bourazopoulou E, Kapsogeorgou EK et al (2005). Functional Toll-like receptors (TLRs) are expressed by cultured salivary gland epithelial cells: increased mRNA expression of TLR-1, -2 and -4 in cells derived from patients with primary Sjögren's syndrome. Arthritis Rheum 52: 278 (abstract 684).
78. Takeda K, Kaisho T, Akira S (2003). Toll-like receptors. Annu Rev Immunol 21: 335-376.
79. Talal N, Dauphinee MJ, Dang H, Alexander SS, Hart DJ, Garry RF (1990). Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy). Arthritis Rheum 33: 774-781.
80. Tandon N, Makgoba MW, Gahmberg CG, Weetman AP (1992). The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cells. Clin Immunol Immunopathol 64: 30-35.
81. Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM (2004). Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis 63: 1159-1161.
82. Thery C, Zitvogel L, Amigorena S (2002). Exosomes: composition, biogenesis and function. Nat Rev Immunol 2: 569-579.
83. Thieblemont C, Mayer A, Dumontet C et al (2002). Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 87: 105-111.
84. Thien M, Phan TG, Gardam S et al (2004). Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20: 785-798.
85. Triantafyllopoulou A, Tapinos N, Moutsopoulos HM (2004). Evidence for coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum 50: 2897-2902.
86. Tsubota K, Fujita H, Tsuzaka K, Takeuchi T (2003). Quantitative analysis of lacrimal gland function, apoptotic figures, Fas and Fas ligand expression of lacrimal glands in dry eye patients. Exp Eye Res 76: 233-240.
87. Tsunawaki S, Nakamura S, Ohyama Y et al (2002). Possible function of salivary gland epithelial cells as non-professional antigen-presenting cells in the development of Sjögren's syndrome. J Rheumatol 29: 1884-1896.
88. Vitali C, Bombardieri S, Jonsson R et al (2002). Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558.
89. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM (1999). Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 42: 1765-1772.
90. Wallaert B, Prin L, Hatron PY, Ramon P, Tonnel AB, Voisin C (1987). Lymphocyte subpopulations in bronchoalveolar lavage in Sjögren's syndrome. Evidence for an expansion of cytotoxic/suppressor subset in patients with alveolar neutrophilia. Chest 92: 1025-1031.
91. Xanthou G, Tapinos NI, Polihronis M, Nezis IP, Margaritis LH, Moutsopoulos HM (1999). CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome. Clin Exp Immunol 118: 154-163.
92. Xanthou G, Polihronis M, Tzioufas AG, Paikos S, Sideras P, Moutsopoulos HM (2001). "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum 44: 408-418.
93. Yamadori I, Fujita J, Bandoh S et al (2002). Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int 22: 89-92.
94. Youssef WI, Tavill AS (2002). Connective tissue diseases and the liver. J Clin Gastroenterol 35: 345-349.
95. Zinkernagel RM (2002). Anti-infection immunity and autoimmunity. Ann N Y Acad Sci 958: 3-6.
96. Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005). The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165: 2337-2344.